Chromosomal rearrangements that fuse amino terminal sequences of the Bcr protein to carboxyl terminal sequences of the Abl tyrosine kinase (p210 Bcr-Abl) are associated with virtually all cases of chronic myelogenous leukemia (CML). Whereas the contribution of Abl encoded sequences to Bcr-Abl-mediated leukemogenesis are relatively well understood, the contribution from the Bcr encoded sequences is unclear. For example, several in vitro studies have identified catalytic activities within the amino terminus of Bcr, yet the relationship of these activities to the in vivo functions of Bcr, and Bcr-Abl, are not known. We have recently completed two studies which suggest that Bcr may contribute to the transforming activity of Bcr-Abl in ways that were not previously realized. First, we have identified a functional interaction between Bcr and the oncogenic transcription factor c-Myc. The disruption of this interaction may account for the elevated levels of c-Myc expression that are observed in Bcr-Abl transformed cells. Consistent with this, we have observed that c-Myc protein levels are sensitive to the dosage of Bcr in a CML-derived leukemic cell line. Second, we have demonstrated that the central RhoGEF domain of Bcr (which is retained in Bcr-Abl) contains in vivo catalytic, signaling and transforming activity. Importantly, a similar catalytic activity is observed within the context of p210 Bcr-Abl. The objective of this proposal is to characterize these new activities, and determine their fates within the context of Bcr-Abl. Specifically, we propose to (1) determine if the association of Bcr with the c-Myc transcription factor has functional consequences that contribute to Bcr-Abl-mediated transformation, and (2) determine whether the transforming and catalytic activities that we have mapped to the RhoGEF domain of Bcr contribute to Bcr-Abl-mediated transformation. The results from these studies should contribute substantially to our knowledge of the molecular basis of Philadelphia chromosome positive leukemias.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA097066-02
Application #
6731984
Study Section
Special Emphasis Panel (ZRG1-CAMP (01))
Program Officer
Mufson, R Allan
Project Start
2003-04-03
Project End
2007-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
2
Fiscal Year
2004
Total Cost
$276,790
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Fitzpatrick, Ethan R; Hu, Tinghui; Ciccarelli, Bryan T et al. (2014) Regulation of vesicle transport and cell motility by Golgi-localized Dbs. Small GTPases 5:1-12
Pannucci, N L; Li, D; Sahay, S et al. (2013) Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity. Blood Cancer J 3:e135
Chen, Ru; Hu, Tinghui; Mahon, Gwendolyn M et al. (2013) Ubiquitin-mediated interaction of p210 BCR/ABL with ?-catenin supports disease progression in a murine model for chronic myelogenous leukemia. Blood 122:2114-24
Tala, I; Chen, R; Hu, T et al. (2013) Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression. Leukemia 27:1080-9
Adams 3rd, Homer C; Chen, Ru; Liu, Zhuoming et al. (2010) Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein. Breast Cancer Res 12:R69
Liu, Zhuoming; Adams 3rd, Homer C; Whitehead, Ian P (2009) The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J Biol Chem 284:15771-80
Sahay, S; Pannucci, N L; Mahon, G M et al. (2008) The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Oncogene 27:2064-71
Rodriguez, Pedro L; Sahay, Sutapa; Olabisi, Oyenike O et al. (2007) ROCK I-mediated activation of NF-kappaB by RhoB. Cell Signal 19:2361-9
Kostenko, Elena V; Olabisi, Oyenike O; Sahay, Sutapa et al. (2006) Ccpg1, a novel scaffold protein that regulates the activity of the Rho guanine nucleotide exchange factor Dbs. Mol Cell Biol 26:8964-75
Olabisi, Oyenike O; Mahon, Gwendolyn M; Kostenko, Elena V et al. (2006) Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res 66:6250-7

Showing the most recent 10 out of 13 publications